- cafead   Feb 11, 2025 at 10:12: PM
via The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare genetic disorder, which causes tumors to grow on nerves throughout the body.
article source
article source